TOKYO —

Memory lapses, skin thinning, and the gradual loss of bone density—these are commonly accepted hallmarks of aging. However, groundbreaking research in mice suggests a unifying biological mechanism might underlie these disparate signs of senescence, pointing to a critical protein within the brain that could act as a central regulator of the aging process. Experiments conducted by a team of scientists at Xiamen University have identified a protein called Menin, predominantly found in the hypothalamus, that appears to significantly influence these age-related declines. The findings, published in the open-access journal PLOS Biology on March 16, 2023, revealed that restoring Menin levels in aging mice not only reversed several physical signs of aging but also improved cognitive function. This discovery opens a new avenue of inquiry into the intricate relationship between brain health, inflammation, and the aging of the entire organism.

The Hypothalamus: A Master Regulator of Aging

The research team focused their investigation on the hypothalamus, a small but vital region of the brain responsible for orchestrating a multitude of essential bodily functions, including metabolism, temperature regulation, and hormonal balance. Increasingly, the hypothalamus is recognized as a key player in the aging process itself. As we age, inflammatory signaling within this brain region tends to escalate. This neuroinflammation, in turn, can trigger a cascade of detrimental effects, impacting both the brain’s intricate circuitry and tissues throughout the body.

Prior to the 2023 study, lead researcher Lige Leng and her colleagues had established that Menin plays a crucial role in suppressing inflammation within the hypothalamus. This prior work naturally led to a pivotal question: could a decline in this protective Menin function be a significant driver of age-related deterioration?

Menin’s Decline in Aging Neurons

The study’s initial observations revealed a striking pattern: Menin levels diminished with age specifically in certain neurons within the ventromedial hypothalamus (VMH), a sub-region of the hypothalamus critical for metabolic regulation. Importantly, this decline was not observed in astrocytes and microglia, which are glial cells that provide support and immune surveillance for the brain. This cell-specific reduction suggested that the loss of Menin was not a generalized aging phenomenon but a targeted deficit in particular neuronal populations crucial for maintaining hypothalamic integrity.

To directly test the hypothesis that Menin deficiency contributes to aging, the researchers employed a sophisticated genetic technique. They engineered conditional knockout mice, allowing them to selectively remove Menin from specific cells. When Menin was reduced in younger mice, the results were dramatic. These animals exhibited increased hypothalamic inflammation and prematurely developed several hallmarks of aging, including reduced bone mass, thinning of the skin, cognitive impairment, and a notably shorter lifespan, underscoring Menin’s critical role in preventing premature senescence.

The D-Serine Connection: Bridging Brain Chemistry and Cognition

Beyond its anti-inflammatory role, the study uncovered another significant pathway through which Menin influences aging: its impact on neurotransmitter signaling. Menin deficiency was found to disrupt a key chemical pathway essential for communication between brain cells. Specifically, mice with lower Menin levels showed reduced concentrations of D-serine, an amino acid that plays a crucial role in modulating the activity of NMDA receptors. These receptors are fundamental to synaptic plasticity, the process by which the strength of connections between neurons is adjusted, a mechanism vital for learning and memory formation.

The research indicated that an enzyme responsible for producing D-serine, which itself is regulated by Menin, became less active in the absence of sufficient Menin. This reduction in enzymatic activity led to a diminished supply of D-serine, thereby impairing neuronal communication and cognitive function. This finding suggested that Menin’s influence on cognition extends beyond its role in mitigating inflammation, actively contributing to the maintenance of the biochemical environment necessary for robust brain signaling.

Clarifying D-Serine Supplementation

The study also addressed the potential for D-serine as a therapeutic agent, a topic that often becomes muddled in discussions of dietary supplements. It’s important to distinguish between dietary serine and the specific amino acid used in experimental treatments. Serine is found in various foods, including soybeans, eggs, fish, and nuts. However, the form of serine incorporated into dietary proteins is primarily L-serine. While the human body can convert L-serine to D-serine, these two forms are not directly interchangeable, and consuming foods rich in L-serine does not equate to the direct administration of D-serine used in scientific studies. This distinction is crucial for accurately interpreting research findings related to D-serine supplementation.

Rejuvenation in Older Mice: Restoring Menin’s Protective Power

The researchers then turned their attention to whether reintroducing Menin could reverse existing aging-related deficits. In a compelling experiment, they delivered the gene for Menin into the hypothalamus of elderly mice, approximately 20 months old, prompting their hypothalamic cells to produce increased amounts of the protein.

The results observed 30 days later were remarkable. The treated mice showed significant improvements in skin thickness and bone mineral density, physical markers of rejuvenation. Furthermore, their performance on tests assessing learning, cognitive abilities, and balance saw notable enhancements. These physical and cognitive improvements were accompanied by elevated D-serine levels in the hippocampus, a brain region indispensable for memory consolidation. Perhaps most strikingly, the study reported that restoring Menin in these older mice also extended their lifespan.

In parallel, a separate experiment explored a more direct approach: administering D-serine to mice via their drinking water for three weeks. This intervention successfully improved cognitive performance, even in older animals. However, it did not replicate the broad improvements in physical aging traits observed after Menin restoration. This crucial finding emphasized that while D-serine supplementation might offer cognitive benefits, it does not appear to reverse systemic aging across the entire body in the same way that restoring Menin does.

At the time of the study’s publication, Dr. Lige Leng articulated the potential significance of their findings, stating, "We speculate that the decline of Menin expression in the hypothalamus with age may be one of the driving factors of aging, and Menin may be the key protein connecting the genetic, inflammatory, and metabolic factors of aging. D-serine is a potentially promising therapeutic for cognitive decline." She further elaborated, "Ventromedial hypothalamus (VMH) Menin signaling diminished in aged mice, which contributes to systemic aging phenotypes and cognitive deficits. The effects of Menin on aging are mediated by neuroinflammatory changes and metabolic pathway signaling, accompanied by serine deficiency in VMH, while restoration of Menin in VMH reversed aging-related phenotypes."

Subsequent Research: Broadening the Perspective

Since the initial publication of the Menin study, a growing body of research has begun to explore related biological mechanisms, although these should be viewed as complementary rather than direct confirmations of the entire Menin-driven aging pathway.

Menin’s Protective Role in Stress Response

In March 2024, a study published in the Journal of Physiology and Biochemistry investigated Menin’s function in cultured mouse hippocampal cells subjected to stress induced by the hormone corticosterone. The researchers found that a compound called itaconate, known for its anti-inflammatory properties, increased Menin levels and subsequently reduced inflammation and a specific form of cell death. When Menin expression was suppressed, this protective effect was lost. While this study, conducted in a cell culture setting rather than in live animals, supported Menin’s protective role, it did not directly demonstrate a slowing of aging in a whole organism.

Hypothalamic Signals and Systemic Aging

Other research has reinforced the critical role of communication between the hypothalamus and the rest of the body in influencing aging. A 2024 study in Cell Metabolism identified a distinct population of hypothalamic neurons that communicate with adipose tissue. Interventions aimed at maintaining or stimulating this neural network led to increased physical activity and extended lifespan in mice. Although this research involved a different molecular pathway than Menin, it strongly supported the broader concept that signals originating from the brain can profoundly impact aging processes beyond the brain itself.

Mapping Aging in the Mouse Brain

A comprehensive analysis of approximately 1.2 million mouse brain cells, published in Nature in January 2025 by an Allen Institute team, provided a larger-scale map of aging-related changes. This study revealed that certain cell types exhibiting the greatest sensitivity to aging were concentrated around the third ventricle of the hypothalamus. Many of these cells displayed reduced activity in genes associated with neuronal function and increased activity in genes related to immune responses. While this research focused on mapping age-associated cellular changes rather than testing interventions, it further highlighted the hypothalamus as a critical area for ongoing aging research.

D-Serine: A Nuanced Role in Brain Health

Later research has also introduced a more complex perspective on the benefits of increasing D-serine levels in the aging brain, suggesting that the relationship is not always straightforward.

D-Serine’s Dual Nature in Alzheimer’s Models

In April 2025, a study published in Cellular and Molecular Life Sciences examined mice genetically engineered to exhibit features of Alzheimer’s disease. In this specific model, an early increase in D-serine coincided with disruptions in brain signaling. Intriguingly, genetically removing the enzyme responsible for D-serine production prevented or mitigated several later-stage cognitive problems. While this study involved a different biological context than the Menin experiments, it demonstrated that D-serine can exert varied effects depending on the underlying disease pathology.

L-Serine vs. D-Serine in Alzheimer’s Research

Further complicating the picture, research published on September 16, 2026, in the Journal of Alzheimer’s Disease explored a different Alzheimer’s mouse model. In this instance, a diet enriched with L-serine led to elevated levels of both L-serine and D-serine in the blood. This dietary intervention partially restored measures of new neuron production in the hippocampus but did not affect the accumulation of amyloid, a protein associated with Alzheimer’s disease. It is critical to note that this experiment investigated the effects of L-serine supplementation and its impact on neurogenesis, rather than the direct administration of D-serine as a treatment for human aging.

Collectively, these later findings suggest that serine metabolism is a promising area for scientific investigation but underscore that "more is not always better." The specific form of serine, the health condition being studied, and the precise outcome being measured are all critical factors that significantly influence the observed effects. Neither of these subsequent studies directly confirms or refutes the original Menin research findings.

Implications for Human Health: Promise and Prudence

While the Menin study offers a compelling glimpse into potential mechanisms of aging, translating these findings to human health requires careful consideration. Existing human research on D-serine, though limited, does not yet establish it as an anti-aging treatment. A small randomized study conducted in 2016, predating the Menin research, administered a single dose of D-serine to 50 healthy older adults. Participants showed improvement on one specific computerized maze task, but no significant benefits were observed on other cognitive tests or mood measures. This experiment did not demonstrate lasting memory enhancements, a slowing of the aging process, or the safety of prolonged D-serine use in older populations.

The Menin findings raise several important questions that remain unanswered. Researchers are still working to identify the precise factors that trigger Menin’s decline with age. Furthermore, the extent to which age-related physical and cognitive deterioration can be prevented or reversed by Menin restoration, and the duration of any such benefits, are subjects for future investigation. The potential for unintended side effects from altering Menin pathways or supplementing with D-serine also warrants thorough examination.

Despite these unknowns, the central hypothesis remains profoundly compelling: that certain aspects of aging may be significantly influenced by signaling pathways originating within a small, specialized region of the brain. Unlocking the secrets of these hypothalamic signals could pave the way for novel strategies to preserve cognitive and physical function later in life. For now, however, the evidence points to an exciting experimental avenue worthy of dedicated scientific exploration, rather than a readily available supplement proven to reverse human aging.